Rightway

Despite its reputation, NADAC is still a single-index pricing model applied to a complex, fast-moving market. It leaves gaps in coverage, lags behind real-time price changes, and ignores key cost factors. In our latest blog, we break down why NADAC isn’t the solution it appears to be and why a flexible, multi-benchmark model is the answer. Read the full blog here: https://bit.ly/42DtpGO #PBM #PharmacyBenefits #DrugPricing #NADAC #Rightway

At ReWork Health, Amir Dan Rubin, CEO and Founding Managing Partner of Healthier Capital, emphasized that employers aren’t just participants in healthcare—they’re the key to healthcare transformation. When employers adopt innovative solutions and push for better outcomes, they influence the healthcare system faster than any other player. See more key moments and insights from ReWork Health 2025 here: bit.ly/4j6D9Pt

Dr. Shereef Elnahal, former Under Secretary for Health at the Department of Veterans Affairs, joined us at ReWork Health last month to discuss the often-overlooked power of trust in leadership. He covered how building trust in small moments prepares teams to move quickly and confidently during big ones. Whether it’s replacing a coffee machine or rethinking crisis communication, the most effective leaders are the ones who lead with empathy, listen often, and act with intention. See more insights from ReWork Health 2025 here: bit.ly/4j6D9Pt

Rightway’s Shawn Earl, Director of PBM Specialty Pharmacy Strategy, and Chad Frazier, Regional VP of PBM sales, are joining Nava Benefits to break down what employers really need to know about GLP-1s and specialty meds. If you're concerned about costs, coverage, and outcomes, this is the webinar to watch. Don't miss it on April 17th: https://lnkd.in/gbQ_JFKe

At ReWork Health 2025, we were joined by Lance Armstrong, seven-time Tour de France winner and Managing Partner of Next Ventures. He brought a personal lens to what it means to lead, grow, and rebuild. His session taught us that resilience isn’t built during the easy times. Whether in elite sports or business, it’s the setbacks, the hard choices, and the discipline in the in-between moments that shape real success. Get the full recap and takeaways from ReWork Health here: bit.ly/4j6D9Pt

How do you lead in a world where the pace of innovation outpaces prediction? Vinod Khosla, founder of Khosla Ventures, challenged us at ReWork Health to think differently about AI’s role in healthcare and the workplace. His message was clear: AI is evolving quickly, and no one can fully predict what’s next. Therefore, you need to stay adaptable. For employers, that means partnering with flexible solutions, embracing data over assumptions, and being ready to evolve as the landscape shifts. Explore more key moments and insights from ReWork Health 2025 here: bit.ly/4j6D9Pt

Earlier this month, we brought together top employers, benefits innovators, and industry leaders at the stunning Stanly Ranch in Napa, California, for ReWork Health 2025—an event dedicated to reshaping healthcare for the better. We tackled important topics like AI in healthcare, employer-driven innovation, leadership in crisis, and the future of benefits. There was no shortage of bold ideas and breakthrough thinking. Explore the full recap here: bit.ly/4j6D9Pt

Transparency is the bare minimum. At Rightway, our aligned financial model goes further, driving real savings and giving our clients peace of mind. The results speak for themselves: + 16.1% average savings on pharmacy costs for plan sponsors. + 11.2% reduction in out-of-pocket expenses for members. Want to learn more? Watch the full webinar to see how Rightway is leading industry change: https://bit.ly/4bx50FV

As biosimilars continue to evolve, what steps can employers take to stay ahead? On last week’s PBM webinar, Hemal Patel, Director of Strategic Accounts, covered how Rightway is deploying innovative biosimilar management strategies, including: + Leveraging our success with Humira to ensure a seamless transition to Stelara biosimilars. + Building a formulary dedicated to autoimmune care to optimize cost savings and patient outcomes. + Utilizing our clinical expertise and navigation strategies to help clients achieve both immediate savings and long-term value around biosimilars. For more details on how you can future-proof your biosimilar strategy, watch the full webinar recording here: https://bit.ly/4bx50FV

In our latest webinar, Rightway’s leaders broke down how we’re scaling smarter and delivering more to our clients and members. We covered: + How Rightway has scaled while maintaining its signature quality, industry-leading service, and measurable savings. + Why member service is essential for a PBM to deliver the best care and health outcomes. + Ways employers can future-proof their pharmacy strategy with biosimilars, GLP-1s, and custom plan designs. + The reasons switching from traditional PBMs isn’t a risk—but staying with them is. 🔗 Watch the full webinar recording here: https://bit.ly/4bx50FV